trending Market Intelligence /marketintelligence/en/news-insights/trending/-hpGd1yqqfcHI7vDMjtbCw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Aerpio Pharmaceuticals names CEO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Aerpio Pharmaceuticals names CEO

Stephen Hoffman will become the CEO of Aerpio Pharmaceuticals Inc. on Dec. 1.

Hoffman succeeds Joseph Gardner, the founder of the company, who will continue to serve as president.

Hoffman joins the company from PDL BioPharma Inc., an investment firm.